Clinical Trial Update: Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous apoptotic cell therapy for rheumatoid arthritis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Autologous apoptotic cell therapy

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Arthritis, Rheumatoid | Phase 1, Phase 2 | Status: UNKNOWN